BRIEF published on 03/10/2025 at 13:04, 1 year 6 months ago BlackRock reduces its stake in ARKEMA Actions Asset Management Participation BlackRock ARKEMA
PRESS RELEASE published on 03/10/2025 at 12:59, 1 year 6 months ago Franchissement de seuil Déclaration de franchissement de seuil par BlackRock Inc. pour ARKEMA. Baisse à 4,81% du capital et 3,85% des droits de vote Déclaration Franchissement De Seuil Baisse BlackRock Inc. ARKEMA
BRIEF published on 02/26/2025 at 08:35, 1 year 6 months ago Arkema Expands PVDF Production in North America Sustainability North America Lithium-ion Batteries ARKEMA PVDF Expansion
BRIEF published on 02/26/2025 at 08:35, 1 year 6 months ago Arkema étend sa production de PVDF en Amérique du Nord Durabilité Batteries Lithium-ion Amérique Du Nord ARKEMA Extension PVDF
PRESS RELEASE published on 02/26/2025 at 08:30, 1 year 6 months ago Inside Information / Other news releases Arkema to increase PVDF capacity by 15% in North America with $20 million investment in Kentucky plant to meet demand in lithium-ion batteries, semiconductor, and cable markets North America Investment Capacity Expansion ARKEMA PVDF
PRESS RELEASE published on 02/26/2025 at 08:30, 1 year 6 months ago Informations privilégiées / Autres communiqués Arkema augmente de 15% sa capacité de PVDF en Amérique du Nord pour soutenir la demande croissante en résines de haute performance, semi-conducteurs et batteries lithium-ion Investissement Amérique Du Nord ARKEMA Capacité PVDF
BRIEF published on 02/25/2025 at 10:29, 1 year 6 months ago Arkema Conducts Share Buyback Transactions Share Buyback EU Regulations ARKEMA Paris Market 2025 Transactions
BRIEF published on 02/25/2025 at 10:29, 1 year 6 months ago Arkema procède à des opérations de rachat d'actions Rachat D'actions ARKEMA Règlements De L'UE Marché De Paris Transactions 2025
PRESS RELEASE published on 02/25/2025 at 10:24, 1 year 6 months ago Inside Information / Other news releases Arkema discloses trading in own shares from 17 to 21 February 2025, in compliance with regulations. Total of 22,500 shares repurchased at a weighted average price of 81.5923. Details on Arkema website Share Buyback Trading Own Shares ARKEMA Weighted Average Price
PRESS RELEASE published on 02/25/2025 at 10:24, 1 year 6 months ago Informations privilégiées / Autres communiqués Arkema annonce les transactions sur actions propres effectuées du 17 au 21 février 2025 dans le respect de la réglementation financière. Consultez le lien pour plus d'informations Actions Propres Réglementation Financière Transactions Investisseurs ARKEMA
Published on 09/11/2026 at 04:00, 7 hours 6 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 12 hours 41 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 19 hours 46 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 20 hours 6 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 10:15, 51 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 09:20, 1 hour 46 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 2 hours 1 minute ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 2 hours 6 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 4 hours 6 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 4 hours 6 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 15 hours 36 minutes ago Availability of the 2026 Interim Financial Report
